The emerging role of psilocybin and MDMA in the treatment of mental illness

Hartej Gilla Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;b Institute of Medical Science, University of Toronto, Toronto, ON, CanadaView further author information

Barjot Gilla Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

David Chen-Lia Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

Sabine El-Halabia Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

Nelson B. Rodriguesa Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

https://orcid.org/0000-0002-8128-5612 View further author information

Danielle S. Chaa Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;c School of Medicine, Faculty of Medicine, University of Queensland, Brisbane, Australia

https://orcid.org/0000-0001-7155-1158 View further author information

Orly Lipsitza Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

Yena Leea Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;b Institute of Medical Science, University of Toronto, Toronto, ON, CanadaView further author information

Joshua Daniel Rosenblata Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;d Department of Psychiatry, University of Toronto, Toronto, ON, Canada;e Brain and Cognition Discovery Foundation, Toronto, ON, CanadaView further author information

Amna Majeeda Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

Rodrigo B. Mansura Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;d Department of Psychiatry, University of Toronto, Toronto, ON, CanadaView further author information

Flora Nasria Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, CanadaView further author information

Roger Hof Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;g Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, SingaporeView further author information

Roger S. McIntyrea Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;b Institute of Medical Science, University of Toronto, Toronto, ON, Canada;d Department of Psychiatry, University of Toronto, Toronto, ON, Canada;e Brain and Cognition Discovery Foundation, Toronto, ON, Canada;h Department of Pharmacology, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
View further author information

show all

The emerging role of psilocybin and MDMA in the treatment of mental illness

Articles from other publishers (22)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The emerging role of psilocybin and MDMA in the treatment of mental illness

Citations (27)

Read on this site (5)

Articles from other publishers (22)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date